Our strengths

What makes Atessia the ideal partner to turn your projects into success?Our approach

Our approach

Our approach

  • Active Listening: Active listening for personalized solutions.
  • Excellence in Action: Expertise aimed at operational excellence.
  • Trusted Partnership: Building strong and long-lasting relationships based on trust.
  • Commitment to Results: We are committed to delivering results that meet your expectations.
  • Certified Quality: A rigorous methodological approach, compliant with the ISO 9001 standard.

Accédez à la charte éthique d'ATESSIA

Our ethical charter embodies the principles and core values guiding each of our actions in the regulatory and pharmaceutical sector. Designed to ensure trust, respect, and transparency, this charter reflects our dedication to excellence, both towards our clients and the entire community

Our values

Atessia +

ISO 9001: 2015 certification granted by AFNOR
in the following fields:
"Consulting, Expertise, Intelligence and Training in the pharmaceutical and regulatory environment of the Health Industries"

Our ISO 9001 certification demonstrates ATESSIA’s ability to consistently provide a product or a service conforming to both customer requirements and those of the applicable regulations, as well as our commitment to increase customer satisfaction.

QUALIOPI certification granted by AFNOR
for our in-company training services

Our Qualiopi certification attests the quality of the process implemented by ATESSIA in the development and the delivery of its professional training courses, which contributes to the development of skills and allows companies to access public and mutualized funding

"Research Tax Credit" approval issued by the Ministry of Research.

ATESSIA is committed to its clients in order to facilitate their Research and Development work. In 2019, ATESSIA applied for and successfully obtained its CIR (Research Tax Credit) accreditation issued by the Ministry of Higher Education, Research and Innovation (MESRI). The accreditation is valid for 3 years and can be renewed.

Thus, our clients will be able to benefit from a corporate tax refund at the end of the fiscal year as a result of the CIR accreditation. Indeed, the expenses that can give right to the CIR are the R&D expenses entrusted either to public organisations, universities, public utility foundations and associations under the 1901 law engaged in Research and Development, or to organizations approved by the Ministry in charge of Research.

The tax credit will therefore be valid for contractual services provided that the work undertaken meets the requirements of Research and Development.

Do not hesitate to contact us for any questions. Our team dedicated to R&D projects is at your disposal.

ATESSIA is SME certified by the European Medicines Agency.

ATESSIA is an innovative company that can help you innovate and access the European market!

SMEs are a driver of innovation in the pharmaceutical sector and play a key role in the development of new medicines.

But for small companies, finding their way through EU rules and regulations can be a challenge.

ATESSIA is SME certified by the European Medicines Agency.

The SME initiative has been put in place by the EMA in order to promote innovation and the development of new medicinal products by smaller companies.

The EU incentives offered by EMA apply to both the human and veterinary sectors, and include:

  • Regulatory, administrative and procedural assistance from the Agency’s SME office including SME briefing meetings
  • Fee incentives (reductions, exemptions) for regulatory procedures such as Scientific advice on medicine development plans, MA applications, Inspections.
  • After MA approval, EMA also provides translations of product information in all EU languages, free of charge.

ATESSIA can make non-EEA SME companies benefit from the European Medicines Agency SME incentives : SME regulatory consultancies may seek to benefit from the provisions of the SME Regulation on behalf of non-EEA based clients, if both they and the client meet the SME criteria:

Headcount: The company and its subsidiaries should have less than 250 employees

Financial thresholds:  Annual turnover ≤  € 50 million or Balance sheet ≤ € 43 million

ISO 9001: 2015 certification granted by AFNOR
in the following fields:
"Consulting, Expertise, Intelligence and Training in the pharmaceutical and regulatory environment of the Health Industries"

The ISO 9001 certification is an internationally recognized standard, attesting to the excellence and quality of services and products offered by a company. It represents our commitment to our partners and clients, ensuring the impeccable quality of our services. For ATESSIA, holding this certification means that we have implemented a recognized and validated quality management system by AFNOR, one of the most respected authorities in the standardization field. This recognition underscores our ability to consistently provide relevant and tailored Consulting, Expertise, Monitoring, and Training services for the pharmaceutical sector and healthcare industries. Obtaining the ISO 9001 certification by ATESSIA is not just about a label or recognition. It is evidence of our commitment to fully satisfy our clients. It ensures that our services are regularly assessed and improved to meet the highest quality standards. Our primary goal is to ensure that the services we provide meet the needs of our clients while complying with the legal and regulatory requirements specific to our area of expertise. At ATESSIA, we are proud of this certification as it reflects our ongoing commitment to provide cutting-edge solutions while respecting the legal and regulatory requirements in the pharmaceutical sector.

QUALIOPI certification granted by AFNOR
for our in-company training services

Our Qualiopi certification attests the quality of the process implemented by ATESSIA in the development and the delivery of its professional training courses, which contributes to the development of skills and allows companies to access public and mutualized funding.

"Research Tax Credit" approval issued by the Ministry of Research.

ATESSIA is dedicated to supporting its clients in facilitating their Research and Development efforts. In 2019, ATESSIA applied for and successfully obtained its CIR (Research Tax Credit) accreditation from the Ministry of Higher Education, Research and Innovation (MESRI). This accreditation is valid for three years and can be renewed.

As a result of the CIR accreditation, our clients can benefit from a corporate tax refund at the end of the fiscal year. Specifically, expenses that qualify for the CIR are R&D costs entrusted to public organizations, universities, public utility foundations, and associations governed by the 1901 law that engage in Research and Development, or to entities approved by the Ministry responsible for Research.

The tax credit is applicable for contractual services, provided that the work undertaken aligns with Research and Development criteria.

For any questions, please don’t hesitate to contact us. Our team, dedicated to R&D projects, is at your service.


ATESSIA is SME certified by the European Medicines Agency.

ATESSIA is an innovative company poised to assist you in innovating and accessing the European market!

SMEs drive innovation in the pharmaceutical sector and play a pivotal role in the development of new medicines.

However, for smaller companies, navigating EU rules and regulations can be daunting.

ATESSIA is certified as an SME by the European Medicines Agency (EMA).

The EMA established the SME initiative to foster innovation and encourage the development of new medicinal products by smaller entities.

The EU incentives offered by the EMA span both human and veterinary sectors and include:

  • Regulatory, administrative, and procedural assistance from the Agency’s SME office, including SME briefing meetings.
  • Fee incentives, such as reductions and exemptions, for regulatory procedures like scientific advice on medicine development plans, marketing authorization (MA) applications, and inspections.
  • Post-MA approval, the EMA also provides free translations of product information in all EU languages.

ATESSIA can help non-EEA SMEs capitalize on the European Medicines Agency’s SME incentives. Regulatory consultancies for SMEs can leverage the provisions of the SME Regulation on behalf of non-EEA-based clients, provided both the consultancy and the client satisfy the SME criteria:

Headcount: The company, along with its subsidiaries, should employ fewer than 250 individuals.

Financial thresholds: Annual turnover should be ≤ €50 million or a balance sheet total of ≤ €43 million

Atessia's CSR Charter, a sign of our commitment to social, societal and environmental responsibility.

At ATESSIA, we have made the decision to adopt a Corporate Social Responsibility (CSR) policy that aligns with our ethical values, focusing on three key areas: environmental, social, and societal. We firmly believe that every action counts and that each decision carries an impact. That is why we are committed to integrating principles of sustainable development into all our activities, reducing our ecological footprint, and fostering a culture of empathy. We invite you to explore our CSR charter, which reflects our dedication to these principles.

Our CSR Charter is available on demand.
  

Atessia's culture is its DNA - it's what gives life to our mission and motivates our collective success

Discover ATESSIA’s Culture Book, a reflection of our identity and history. This collection presents our ambition, mission, values, as well as our founder’s vision. It highlights our defining moments, testimonials from our team members and clients, our rituals, and our perspective on remote work. It’s an invitation to understand who we are and where we aim to go.

Our Culture Book is available on demand.